Abstract

Most of the known inhibitors of d-amino acid oxidase (DAAO) are small polar molecules recognized by the active site of the enzyme. More recently a new class of DAAO inhibitors has been disclosed that interacts with loop 218−224 at the top of the binding pocket. These compounds have a significantly larger size and more beneficial physicochemical properties than most reported DAAO inhibitors, however, their structure-activity relationship is poorly explored. Here we report the synthesis and evaluation of this type of DAAO inhibitors that open the lid over the active site of DAAO. In order to collect relevant SAR data we varied two distinct parts of the inhibitors. A systematic variation of the pendant aromatic substituents according to the Topliss scheme resulted in DAAO inhibitors with low nanomolar activity. The activity showed low sensitivity to the substituents investigated. The variation of the linker connecting the pendant aromatic moiety and the acidic headgroup revealed that the interactions of the linker with the enzyme were crucial for achieving significant inhibitory activity. Structures and activities were analyzed based on available X-ray structures of the complexes. Our findings might support the design of drug-like DAAO inhibitors with advantageous physicochemical properties and ADME profile.

Highlights

  • D -Amino acid oxidase (DAAO) is a flavoprotein that catalyzes the oxidative deamination ofD -amino acids

  • It has been shown from post mortem brain tissue samples of patients who suffered from schizophrenia that DAAO expression and enzyme activity were elevated compared to healthy controls [3]

  • We introduced introduced modifications modificationsin in the the linker linker and and in in the pendant aromatic aromatic part while we used acidic and acid bioisoster headgroups already described for DAAO inhibitors inhibitors [11,13,14,15,16]

Read more

Summary

Introduction

D -Amino acid oxidase (DAAO) is a flavoprotein that catalyzes the oxidative deamination ofD -amino acids. It has been shown from post mortem brain tissue samples of patients who suffered from schizophrenia that DAAO expression and enzyme activity were elevated compared to healthy controls [3]. These findings suggest that the inhibition of DAAO may result in an increase of brain D-serine level and may have positive effect on the symptoms of schizophrenia [4]. First generation DAAO inhibitors 1–6 [5,6,7,8,9,10] are mostly small polar molecules in accordance with the properties of the enzyme active site (Figure 1).

Methods
Results
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.